MED — MEDICLIN AG Income Statement
0.000.00%
Last trade - 00:00- €169.10m
- €401.47m
- €804.32m
Annual income statement for MEDICLIN AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 687 | 722 | 767 | 765 | 804 |
| Cost of Revenue | |||||
| Gross Profit | 565 | 590 | 629 | 636 | 679 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 676 | 703 | 754 | 712 | 749 |
| Operating Profit | 11.6 | 19.5 | 12.7 | 53.5 | 55.4 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 2.45 | 9.78 | -8.69 | 32.1 | 35.2 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1.49 | 9.72 | -10.7 | 24.9 | 25.9 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 1.46 | 9.44 | -10.8 | 24.8 | 25.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1.46 | 9.44 | -10.8 | 24.8 | 25.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.031 | 0.199 | -0.145 | 0.631 | 0.631 |
| Dividends per Share |